name: Proteus syndrome
category: Mendelian
parents: []
disease_term:
  preferred_term: Proteus syndrome
  term:
    id: MONDO:0008318
    label: Proteus syndrome
prevalence:
  - population: Reported cases
    percentage: Rare
    notes: Approximately 250 cases documented in the literature over the past four decades.
    evidence:
      - reference: DOI:10.1186/s13023-023-03013-9
        supports: SUPPORT
        snippet: "Proteus syndrome is an ultra-rare mosaic overgrowth disorder."
        explanation: This statement characterizes Proteus syndrome as ultra-rare.
      - reference: DOI:10.1055/a-2300-7002
        supports: SUPPORT
        snippet: "Proteus syndrome (PS) is an exceptionally uncommon genetic disorder that has been documented in only approximately 250 cases in the literature spanning the past four decades."
        explanation: This provides a literature-based estimate of reported case counts.
  - population: Live births
    percentage: 0.0001
    notes: Estimated prevalence is less than 1 per 1,000,000 live births.
    evidence:
      - reference: PMID:33987133
        supports: SUPPORT
        snippet: "It has an estimated prevalence of less than 1/1,000,000 live births."
        explanation: This case report provides a population prevalence estimate for Proteus syndrome.
epidemiology:
  - name: Sex distribution in imaging cohort
    description: Male predominance reported in a cardiothoracic imaging cohort.
    unit: cases
    notes: In a cohort of 38 imaged individuals, 23 were men.
    evidence:
      - reference: DOI:10.1038/s41598-021-86029-0
        supports: SUPPORT
        snippet: "Of 53 individuals with a confirmed diagnosis of Proteus syndrome at our institution from 10/2001 to 10/2019, 38 individuals (men, n = 23; average age = 24 years) underwent cardiothoracic imaging"
        explanation: This cohort reports a male-predominant sex distribution among imaged individuals.
  - name: Sex distribution in longitudinal cohort
    description: Male predominance reported in a 64-patient natural history cohort.
    unit: cases
    notes: 36 males and 28 females in the cohort.
    evidence:
      - reference: PMID:28661492
        supports: SUPPORT
        snippet: "There were 64 patients with Proteus syndrome identified in this study, 28 (43.8%) were female and 36 were male (56.3%)."
        explanation: The longitudinal cohort reports a modest male predominance.
  - name: Age in imaging cohort
    description: Average age reported for the cardiothoracic imaging cohort.
    mean_range: 24 years
    unit: years
    evidence:
      - reference: DOI:10.1038/s41598-021-86029-0
        supports: SUPPORT
        snippet: "Of 53 individuals with a confirmed diagnosis of Proteus syndrome at our institution from 10/2001 to 10/2019, 38 individuals (men, n = 23; average age = 24 years) underwent cardiothoracic imaging"
        explanation: The imaging cohort reports an average age of 24 years.
  - name: Age at diagnosis
    description: Median age at diagnosis in a natural history cohort.
    mean_range: 19 months
    unit: months
    evidence:
      - reference: PMID:28661492
        supports: SUPPORT
        snippet: "The median age of diagnosis was 19 months."
        explanation: The cohort analysis reports a median diagnosis age of 19 months.
pathophysiology:
  - name: Somatic AKT1 p.E17K activation in mosaic cell clones
    description: >
      Proteus syndrome is caused by a post-zygotic activating AKT1 p.E17K
      variant present in a mosaic subset of cells.
    evidence:
      - reference: DOI:10.1038/srep17162
        supports: SUPPORT
        snippet: "A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-positive cells, is responsible for the mosaic overgrowth condition, Proteus syndrome."
        explanation: This establishes mosaic, somatic AKT1 p.E17K activation in Proteus syndrome.
  - name: Elevated PI3K/AKT signaling in AKT1-mutant cells
    description: >
      AKT1 p.E17K drives increased PI3K/AKT pathway activity in mutation-positive
      cells, promoting downstream overgrowth signals.
    biological_processes:
      - preferred_term: phosphatidylinositol 3-kinase/protein kinase B signal transduction
        term:
          id: GO:0043491
          label: phosphatidylinositol 3-kinase/protein kinase B signal transduction
        modifier: INCREASED
    evidence:
      - reference: DOI:10.1038/srep17162
        supports: SUPPORT
        snippet: "A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-positive cells, is responsible for the mosaic overgrowth condition, Proteus syndrome."
        explanation: This directly links AKT1 activation to elevated AKT signaling in mutation-positive cells.
  - name: Increased pAKT signaling in AKT1-mutant lesion cells
    description: >
      Lesion cells harboring AKT1 p.E17K show increased pAKT signaling within
      hyperplastic regions.
    biological_processes:
      - preferred_term: protein phosphorylation
        term:
          id: GO:0006468
          label: protein phosphorylation
        modifier: INCREASED
    evidence:
      - reference: DOI:10.1093/hmg/ddz116
        supports: SUPPORT
        snippet: "Identification of variant-positive cells by green fluorescent protein (GFP) staining in chimeric Proteus syndrome mice showed that in some lesions, hyperplastic cells were predominantly GFP/Akt1E17K-positive and showed increased pAKT signal compared to GFP-negative cells."
        explanation: This demonstrates increased pAKT signaling in mutant clones within lesions.
  - name: Non-cell-autonomous pAKT activation in adjacent cells
    description: >
      AKT1-mutant clones can induce increased pAKT signaling in nearby
      mutation-negative cells, consistent with non-cell-autonomous lesion
      propagation.
    biological_processes:
      - preferred_term: cell-cell signaling
        term:
          id: GO:0007267
          label: cell-cell signaling
        modifier: INCREASED
    evidence:
      - reference: DOI:10.1093/hmg/ddz116
        supports: SUPPORT
        snippet: "However, hyperplastic mammary epithelium was a mixture of GFP/Akt1E17K-positive and negative cells with some GFP/Akt1E17K-negative cells also having increased pAKT signal suggesting that the variant-positive cells can induce lesion formation in a non-cell autonomous manner."
        explanation: This provides evidence for non-cell-autonomous effects in lesion formation.
  - name: AKT overactivation induces excessive vasculogenesis
    description: >
      AKT1 activation increases vascular connectivity and promotes
      vasculogenesis with enhanced vascular sprouting.
    cell_types:
      - preferred_term: endothelial cell
        term:
          id: CL:0000115
          label: endothelial cell
    biological_processes:
      - preferred_term: vasculogenesis
        term:
          id: GO:0001570
          label: vasculogenesis
        modifier: INCREASED
      - preferred_term: angiogenesis
        term:
          id: GO:0001525
          label: angiogenesis
        modifier: INCREASED
    evidence:
      - reference: DOI:10.1101/2024.01.26.577324
        supports: SUPPORT
        snippet: "Our findings revealed that AKT overactivation in these organoids resulted in smaller sizes yet increased vascular connectivity, although with less stable connections."
        explanation: AKT overactivation increases vascular connectivity in organoid vasculature.
      - reference: DOI:10.1101/2024.01.26.577324
        supports: SUPPORT
        snippet: "This could be due to the significant vasculogenesis induced by AKT overactivation."
        explanation: The study explicitly links AKT overactivation to increased vasculogenesis.
  - name: Mural cell dysfunction destabilizes vascular connections
    description: >
      AKT-driven vascular malformations include dysfunctional PDGFRβ+ mural
      cells with impaired matrix secretion, contributing to unstable vessel
      connections.
    cell_types:
      - preferred_term: pericyte
        term:
          id: CL:0000669
          label: pericyte
    biological_processes:
      - preferred_term: extracellular matrix organization
        term:
          id: GO:0030198
          label: extracellular matrix organization
        modifier: DECREASED
    evidence:
      - reference: DOI:10.1101/2024.01.26.577324
        supports: SUPPORT
        snippet: "Our findings revealed that AKT overactivation in these organoids resulted in smaller sizes yet increased vascular connectivity, although with less stable connections."
        explanation: AKT overactivation is linked to unstable vascular connections.
      - reference: DOI:10.1101/2024.01.26.577324
        supports: SUPPORT
        snippet: "Additionally, a notable increase in dysfunctional PDGFRβ + mural cells, impaired in matrix secretion, was observed in these AKT-overactivated organoids."
        explanation: This supports mural cell dysfunction as part of the vascular phenotype.
phenotypes:
  - name: Overgrowth
    category: Musculoskeletal
    frequency: VERY_FREQUENT
    phenotype_term:
      preferred_term: Overgrowth
      term:
        id: HP:0001548
        label: Overgrowth
    evidence:
      - reference: DOI:10.1093/hmg/ddz116
        supports: SUPPORT
        snippet: "Common manifestations include skin and bony overgrowth, vascular malformations (VMs), cysts and benign tumors."
        explanation: This highlights skin and bony overgrowth as common manifestations.
      - reference: DOI:10.1055/a-2300-7002
        supports: SUPPORT
        snippet: "It is characterized by a disproportionate, asymmetric overgrowth of all types of tissues, provoked by a somatic activating mutation in serine/threonine protein kinase 1."
        explanation: This describes the characteristic disproportionate overgrowth in Proteus syndrome.
      - reference: PMID:22876373
        supports: SUPPORT
        snippet: "Proteus syndrome (PS) is characterized by progressive segmental or patchy overgrowth most commonly affecting the skeleton, skin, adipose, and central nervous systems."
        explanation: GeneReviews describes the hallmark progressive segmental overgrowth in Proteus syndrome.
      - reference: PMID:33987133
        supports: SUPPORT
        snippet: "Proteus syndrome is an extremely rare disorder that manifests as an asymmetric, disproportionate overgrowth of any connective tissue, such as bone, fat or epidermal nevi, in a mosaic or patchy pattern."
        explanation: This case report emphasizes disproportionate connective tissue overgrowth.
  - name: Asymmetric growth
    category: Growth
    frequency: VERY_FREQUENT
    phenotype_term:
      preferred_term: Asymmetric growth
      term:
        id: HP:0100555
        label: Asymmetric growth
    evidence:
      - reference: DOI:10.1055/a-2300-7002
        supports: SUPPORT
        snippet: "It is characterized by a disproportionate, asymmetric overgrowth of all types of tissues, provoked by a somatic activating mutation in serine/threonine protein kinase 1."
        explanation: This explicitly describes asymmetric overgrowth as a defining feature.
      - reference: PMID:33987133
        supports: SUPPORT
        snippet: "Proteus syndrome is an extremely rare disorder that manifests as an asymmetric, disproportionate overgrowth of any connective tissue, such as bone, fat or epidermal nevi, in a mosaic or patchy pattern."
        explanation: This case report underscores asymmetric, disproportionate overgrowth.
  - name: Venous malformation
    category: Cardiovascular
    frequency: FREQUENT
    phenotype_term:
      preferred_term: Venous malformation
      term:
        id: HP:0012721
        label: Venous malformation
    evidence:
      - reference: DOI:10.1093/hmg/ddz116
        supports: SUPPORT
        snippet: "Common manifestations include skin and bony overgrowth, vascular malformations (VMs), cysts and benign tumors."
        explanation: This lists vascular malformations among common Proteus syndrome manifestations.
      - reference: PMID:33987133
        supports: SUPPORT
        snippet: "Many individuals develop cutaneous capillary malformation and prominent varicosities (large and complex vascular malformations)."
        explanation: This documents vascular malformations with prominent varicosities in Proteus syndrome.
  - name: Cerebriform connective tissue nevus
    category: Dermatologic
    frequency: FREQUENT
    phenotype_term:
      preferred_term: Cerebriform connective tissue nevus
      term:
        id: HP:6000009
        label: Cerebriform connective tissue nevus
    evidence:
      - reference: DOI:10.1101/mcs.a006134
        supports: SUPPORT
        snippet: "The patient has experienced sustained improvement of pain and slowed growth of bilateral plantar cerebriform connective tissue nevi."
        explanation: This reports cerebriform connective tissue nevi in Proteus syndrome.
      - reference: PMID:34668833
        supports: SUPPORT
        snippet: "The main histological findings are diffuse patchy overgrowth of skin and subcutaneous tissue, plantar cerebriform connective tissue nevus, and ossification defects."
        explanation: The case report highlights cerebriform connective tissue nevi as a key histologic finding.
  - name: Epidermal nevus
    category: Dermatologic
    frequency: FREQUENT
    phenotype_term:
      preferred_term: Epidermal nevus
      term:
        id: HP:0010816
        label: Epidermal nevus
    evidence:
      - reference: PMID:33987133
        supports: SUPPORT
        snippet: "Proteus syndrome is an extremely rare disorder that manifests as an asymmetric, disproportionate overgrowth of any connective tissue, such as bone, fat or epidermal nevi, in a mosaic or patchy pattern."
        explanation: This case report includes epidermal nevi among overgrowth manifestations.
  - name: Capillary malformation
    category: Cardiovascular
    frequency: FREQUENT
    phenotype_term:
      preferred_term: Capillary malformation
      term:
        id: HP:0025104
        label: Capillary malformation
    evidence:
      - reference: PMID:33987133
        supports: SUPPORT
        snippet: "Many individuals develop cutaneous capillary malformation and prominent varicosities (large and complex vascular malformations)."
        explanation: This documents cutaneous capillary malformations in Proteus syndrome.
  - name: Varicose veins
    category: Cardiovascular
    frequency: FREQUENT
    phenotype_term:
      preferred_term: Varicose veins
      term:
        id: HP:0002619
        label: Varicose veins
    evidence:
      - reference: PMID:33987133
        supports: SUPPORT
        snippet: "Many individuals develop cutaneous capillary malformation and prominent varicosities (large and complex vascular malformations)."
        explanation: Prominent varicosities are reported as part of Proteus syndrome vascular disease.
  - name: Pain
    category: Neurologic
    frequency: OCCASIONAL
    phenotype_term:
      preferred_term: Pain
      term:
        id: HP:0012531
        label: Pain
    evidence:
      - reference: DOI:10.1101/mcs.a006134
        supports: SUPPORT
        snippet: "The patient has experienced sustained improvement of pain and slowed growth of bilateral plantar cerebriform connective tissue nevi."
        explanation: Pain is reported as a symptom improved with targeted therapy.
  - name: Scoliosis
    category: Musculoskeletal
    frequency: FREQUENT
    phenotype_term:
      preferred_term: Scoliosis
      term:
        id: HP:0002650
        label: Scoliosis
    evidence:
      - reference: DOI:10.1038/s41598-021-86029-0
        supports: SUPPORT
        snippet: "The cardiothoracic findings of Proteus syndrome were diverse, but several were much more common and included: scoliosis from bony overgrowth (94%), pulmonary venous dilation (62%), band-like areas of lung scarring (56%), and hyperlucent lung parenchyma (50%)."
        explanation: This provides cohort evidence for scoliosis due to bony overgrowth.
  - name: Emphysema
    category: Respiratory
    frequency: OCCASIONAL
    phenotype_term:
      preferred_term: Emphysema
      term:
        id: HP:0002097
        label: Emphysema
    evidence:
      - reference: DOI:10.1186/s13023-023-03013-9
        supports: SUPPORT
        snippet: "Individuals with Proteus syndrome can develop emphysematous and cystic changes of the lung that may lead to progressive respiratory symptoms and require surgical intervention."
        explanation: This documents emphysematous lung changes in Proteus syndrome.
  - name: Multiple pulmonary cysts
    category: Respiratory
    frequency: OCCASIONAL
    phenotype_term:
      preferred_term: Multiple pulmonary cysts
      term:
        id: HP:0005948
        label: Multiple pulmonary cysts
    evidence:
      - reference: DOI:10.1186/s13023-023-03013-9
        supports: SUPPORT
        snippet: "Individuals with Proteus syndrome can develop emphysematous and cystic changes of the lung that may lead to progressive respiratory symptoms and require surgical intervention."
        explanation: This supports cystic lung changes in Proteus syndrome.
  - name: Deep vein thrombosis
    category: Cardiovascular
    frequency: FREQUENT
    phenotype_term:
      preferred_term: Deep venous thrombosis
      term:
        id: HP:0002625
        label: Deep venous thrombosis
    evidence:
      - reference: PMID:22876373
        supports: SUPPORT
        snippet: "It is associated with a range of tumors, pulmonary complications, and a striking predisposition to deep vein thrombosis and pulmonary embolism."
        explanation: GeneReviews documents a predisposition to deep vein thrombosis in Proteus syndrome.
      - reference: PMID:33987133
        supports: SUPPORT
        snippet: "Thus, Proteus syndrome patients are at risk of developing deep vein thrombosis and pulmonary embolism."
        explanation: This case report confirms thrombotic risk in Proteus syndrome.
  - name: Pulmonary embolism
    category: Cardiovascular
    frequency: FREQUENT
    phenotype_term:
      preferred_term: Pulmonary embolism
      term:
        id: HP:0002204
        label: Pulmonary embolism
    evidence:
      - reference: PMID:22876373
        supports: SUPPORT
        snippet: "It is associated with a range of tumors, pulmonary complications, and a striking predisposition to deep vein thrombosis and pulmonary embolism."
        explanation: GeneReviews identifies pulmonary embolism as a complication in Proteus syndrome.
      - reference: PMID:33987133
        supports: SUPPORT
        snippet: "Thus, Proteus syndrome patients are at risk of developing deep vein thrombosis and pulmonary embolism."
        explanation: This case report reiterates risk of pulmonary embolism.
  - name: Lipoma
    category: Dermatologic
    frequency: OCCASIONAL
    phenotype_term:
      preferred_term: Lipoma
      term:
        id: HP:0012032
        label: Lipoma
    evidence:
      - reference: PMID:37692275
        supports: SUPPORT
        snippet: "Lipomas can run in families (familial multiple lipomatosis) or be a part of genetic syndromes such as PTEN hamartoma tumor syndrome, Proteus syndrome, and Pai syndrome."
        explanation: This review lists lipomas as part of Proteus syndrome presentations.
  - name: Limbal dermoid
    category: Ophthalmologic
    frequency: VERY_RARE
    phenotype_term:
      preferred_term: Limbal dermoid
      term:
        id: HP:0001140
        label: Limbal dermoid
    evidence:
      - reference: PMID:36113118
        supports: SUPPORT
        snippet: "Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen."
        explanation: This case report documents limbal dermoid in Proteus syndrome.
  - name: Cataract
    category: Ophthalmologic
    frequency: VERY_RARE
    phenotype_term:
      preferred_term: Cataract
      term:
        id: HP:0000518
        label: Cataract
    evidence:
      - reference: PMID:36113118
        supports: SUPPORT
        snippet: "Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen."
        explanation: The report lists unilateral cataract among ophthalmic anomalies.
  - name: Nystagmus
    category: Ophthalmologic
    frequency: VERY_RARE
    phenotype_term:
      preferred_term: Nystagmus
      term:
        id: HP:0000639
        label: Nystagmus
    evidence:
      - reference: PMID:36113118
        supports: SUPPORT
        snippet: "Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen."
        explanation: Bilateral nystagmus is reported in a Proteus syndrome patient.
  - name: Myopia
    category: Ophthalmologic
    frequency: VERY_RARE
    phenotype_term:
      preferred_term: Myopia
      term:
        id: HP:0000545
        label: Myopia
    evidence:
      - reference: PMID:36113118
        supports: SUPPORT
        snippet: "Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen."
        explanation: Severe myopia is included among the ophthalmic anomalies.
  - name: Optic disc drusen
    category: Ophthalmologic
    frequency: VERY_RARE
    phenotype_term:
      preferred_term: Optic disc drusen
      term:
        id: HP:0012426
        label: Optic disc drusen
    evidence:
      - reference: PMID:36113118
        supports: SUPPORT
        snippet: "Case #1 describes a 26 year old male patient followed for multiple ophthalmic anomalies: a limbal dermoid cyst, a unilateral cataract, bilateral nystagmus, severe myopia and unilateral optic nerve head drusen."
        explanation: Optic nerve head drusen are reported in a Proteus syndrome patient.
  - name: Proptosis
    category: Ophthalmologic
    frequency: VERY_RARE
    phenotype_term:
      preferred_term: Proptosis
      term:
        id: HP:0000520
        label: Proptosis
    evidence:
      - reference: PMID:37975355
        supports: SUPPORT
        snippet: "Her proptosis and vision impairment were relieved after Endoscope-Navigation system (ENS)-aided optic canal decompression."
        explanation: This case report documents proptosis in Proteus syndrome.
  - name: Visual impairment
    category: Ophthalmologic
    frequency: VERY_RARE
    phenotype_term:
      preferred_term: Visual impairment
      term:
        id: HP:0000505
        label: Visual impairment
    evidence:
      - reference: PMID:37975355
        supports: SUPPORT
        snippet: "Her proptosis and vision impairment were relieved after Endoscope-Navigation system (ENS)-aided optic canal decompression."
        explanation: Vision impairment is reported among ocular manifestations.
  - name: Neoplasm
    category: Oncologic
    frequency: OCCASIONAL
    phenotype_term:
      preferred_term: Neoplasm
      term:
        id: HP:0002664
        label: Neoplasm
    evidence:
      - reference: DOI:10.1136/jmg-2024-110173
        supports: SUPPORT
        snippet: "AKT1-related Proteus syndrome is an ultra-rare mosaic overgrowth disorder with tumour predisposition."
        explanation: This systematic review establishes tumor predisposition in Proteus syndrome.
      - reference: PMID:22876373
        supports: SUPPORT
        snippet: "It is associated with a range of tumors, pulmonary complications, and a striking predisposition to deep vein thrombosis and pulmonary embolism."
        explanation: GeneReviews notes association with a range of tumors.
      - reference: PMID:38074478
        supports: SUPPORT
        snippet: "We report a 35-year-old patient with PS, who underwent successful surgical removal of a well-differentiated SNEC obstructing his nasal cavity"
        explanation: This case report documents sinonasal neuroendocrine carcinoma in Proteus syndrome.
biochemical: []
genetic:
  - name: AKT1
    association: Causative
    notes: Somatic activating mosaic variant (c.49G>A, p.Glu17Lys); HGNC:391
    evidence:
      - reference: DOI:10.1038/srep17162
        supports: SUPPORT
        snippet: "A somatic activating mutation in AKT1, c.49G>A, pGlu17Lys, that results in elevated AKT signaling in mutation-positive cells, is responsible for the mosaic overgrowth condition, Proteus syndrome."
        explanation: This identifies the causative somatic AKT1 variant.
      - reference: DOI:10.1093/hmg/ddz116
        supports: SUPPORT
        snippet: "Proteus syndrome is a mosaic, progressive overgrowth disorder caused by a somatic activating variant c.49G > A p.(E17K) in AKT1."
        explanation: This independently confirms the AKT1 p.E17K mosaic variant as the cause.
environmental: []
treatments:
  - name: AKT inhibitor (miransertib/ARQ 092)
    description: >-
      Allosteric pan-AKT inhibitor used to suppress AKT signaling and evaluated
      clinically for symptom and overgrowth control in Proteus syndrome.
    evidence:
      - reference: DOI:10.1038/srep17162
        supports: SUPPORT
        snippet: "ARQ 092 reduced phosphorylation of AKT and downstream targets of AKT in a concentration-dependent manner in as little as two hours."
        explanation: This shows AKT pathway suppression by ARQ 092 in Proteus syndrome samples.
      - reference: DOI:10.1101/mcs.a006134
        supports: SUPPORT
        snippet: "The patient has experienced sustained improvement of pain and slowed growth of bilateral plantar cerebriform connective tissue nevi."
        explanation: This case report describes clinical benefit with miransertib (ARQ 092).
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
      qualifiers:
        - predicate:
            preferred_term: therapeutic agent
            term:
              id: NCIT:C2259
              label: Therapeutic Agent
          value:
            preferred_term: miransertib
            term:
              id: NCIT:C99172
              label: Miransertib
  - name: Surgical intervention
    description: Surgical debulking or corrective procedures used to manage focal overgrowth and deformity.
    evidence:
      - reference: DOI:10.1055/a-2300-7002
        supports: SUPPORT
        snippet: "We report a case of PS in a two-year-old female patient with the following clinical features: unilateral overgrowth of connective tissue in the right buttock and right foot, where multiple surgeries were performed to achieve a desirable aesthetic outcome and ensure psychological comfort of the young patient."
        explanation: This case report documents surgical intervention for overgrowth management.
    treatment_term:
      preferred_term: surgical procedure
      term:
        id: MAXO:0000004
        label: surgical procedure
differential_diagnoses:
  - name: Klippel-Trenaunay-Weber syndrome
    description: >
      Overgrowth with vascular malformations can resemble Proteus syndrome and
      requires clinical and radiologic differentiation.
    distinguishing_features:
      - Capillary/venous malformations with limb hypertrophy and port-wine stains
      - Typically lacks cerebriform connective tissue nevi
    evidence:
      - reference: PMID:25009745
        supports: SUPPORT
        snippet: "In the current review, four overgrowth syndromes were characterized (Proteus syndrome, Klippel-Trenaunay-Weber syndrome, Madelung's disease, and neurofibromatosis type I) and illustrated using cases from our institution."
        explanation: This review explicitly lists Klippel-Trenaunay-Weber syndrome alongside Proteus syndrome in differential evaluation of overgrowth syndromes.
  - name: Madelung's disease (multiple symmetric lipomatosis)
    disease_term:
      preferred_term: multiple symmetric lipomatosis
      term:
        id: MONDO:0007908
        label: multiple symmetric lipomatosis
    description: >
      Symmetric lipomatous overgrowth can resemble Proteus syndrome and should
      be differentiated based on distribution and accompanying malformations.
    distinguishing_features:
      - Symmetric lipomatous masses rather than mosaic, segmental overgrowth
      - Absence of cerebriform connective tissue nevi
    evidence:
      - reference: PMID:25009745
        supports: SUPPORT
        snippet: "In the current review, four overgrowth syndromes were characterized (Proteus syndrome, Klippel-Trenaunay-Weber syndrome, Madelung's disease, and neurofibromatosis type I) and illustrated using cases from our institution."
        explanation: This review includes Madelung's disease among Proteus syndrome differentials.
  - name: Neurofibromatosis type I
    disease_term:
      preferred_term: neurofibromatosis type 1
      term:
        id: MONDO:0018975
        label: neurofibromatosis type 1
    description: >
      Neurocutaneous overgrowth and benign tumors can overlap with Proteus
      syndrome, but NF1 has distinct diagnostic features.
    distinguishing_features:
      - Cafe-au-lait macules and neurofibromas
      - Lisch nodules and NF1 pathogenic variants
    evidence:
      - reference: PMID:25009745
        supports: SUPPORT
        snippet: "In the current review, four overgrowth syndromes were characterized (Proteus syndrome, Klippel-Trenaunay-Weber syndrome, Madelung's disease, and neurofibromatosis type I) and illustrated using cases from our institution."
        explanation: This review includes neurofibromatosis type I among overgrowth syndromes that overlap with Proteus syndrome.
  - name: CLOVES syndrome
    disease_term:
      preferred_term: CLOVES syndrome
      term:
        id: MONDO:0013038
        label: CLOVES syndrome
    description: >
      Segmental overgrowth with complex vascular and soft tissue malformations
      can overlap with Proteus syndrome presentations.
    distinguishing_features:
      - Typically congenital, with lipomatous truncal overgrowth and vascular malformations
      - PIK3CA-related overgrowth rather than AKT1 mosaic variant
    evidence:
      - reference: PMID:34668833
        supports: SUPPORT
        snippet: "Discussion: CLOVES syndrome, neurofibromatosis 1 or PTEN hamartoma tumor syndrome are partially superimposable entities to Proteus syndrome and may generate diagnostic doubt."
        explanation: This case report lists CLOVES among overlapping entities in differential diagnosis.
  - name: PTEN hamartoma tumor syndrome
    disease_term:
      preferred_term: PTEN hamartoma tumor syndrome
      term:
        id: MONDO:0017623
        label: PTEN hamartoma tumor syndrome
    description: >
      PTEN-related overgrowth and hamartomatous features can mimic Proteus
      syndrome, requiring molecular differentiation.
    distinguishing_features:
      - Germline PTEN variants with systemic hamartomas and cancer predisposition
      - Macrocephaly and mucocutaneous findings typical of PHTS
    evidence:
      - reference: PMID:34668833
        supports: SUPPORT
        snippet: "Discussion: CLOVES syndrome, neurofibromatosis 1 or PTEN hamartoma tumor syndrome are partially superimposable entities to Proteus syndrome and may generate diagnostic doubt."
        explanation: This case report highlights PTEN hamartoma tumor syndrome as a differential.
      - reference: PMID:20301661
        supports: SUPPORT
        snippet: "The PTEN hamartoma tumor syndrome (PHTS) includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), PTEN-related Proteus syndrome (PS), and PTEN-related Proteus-like syndrome."
        explanation: GeneReviews links PTEN hamartoma tumor syndrome to PTEN-related Proteus/Proteus-like presentations.
      - reference: PMID:40058215
        supports: SUPPORT
        snippet: "PTEN hamartomas cause a variety of conditions, including Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, PTEN-related Proteus syndrome, and Proteus-like syndrome."
        explanation: This case report reiterates PTEN-related Proteus syndromes within the PTEN hamartoma spectrum.
  - name: Bannayan-Riley-Ruvalcaba syndrome
    disease_term:
      preferred_term: Bannayan-Riley-Ruvalcaba syndrome
      term:
        id: MONDO:0007924
        label: Bannayan-Riley-Ruvalcaba syndrome
    description: >
      PTEN-related overgrowth syndrome that can overlap with Proteus-like
      features and should be distinguished by germline PTEN findings and classic
      mucocutaneous/hamartomatous manifestations.
    distinguishing_features:
      - Macrocephaly with hamartomatous polyposis and lipomas
      - Germline PTEN variants with systemic findings
    evidence:
      - reference: PMID:20301661
        supports: SUPPORT
        snippet: "The PTEN hamartoma tumor syndrome (PHTS) includes Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), PTEN-related Proteus syndrome (PS), and PTEN-related Proteus-like syndrome."
        explanation: GeneReviews includes BRRS within the PTEN hamartoma tumor syndrome spectrum relevant to Proteus differentials.
clinical_trials:
  - name: NCT04316546
    phase: PHASE_II
    status: RECRUITING
    description: Multi-cohort Phase 2 dose-escalation study of miransertib (MK-7075) in Proteus syndrome.
    evidence:
      - reference: clinicaltrials:NCT04316546
        supports: SUPPORT
        snippet: "To learn if miransertib is a safe and effective treatment for Proteus syndrome."
        explanation: The trial objective confirms evaluation of miransertib for Proteus syndrome.
  - name: NCT02594215
    phase: PHASE_I
    status: COMPLETED
    description: Dose-finding study of MK-7075 (miransertib) in children and adults with Proteus syndrome.
    evidence:
      - reference: clinicaltrials:NCT02594215
        supports: SUPPORT
        snippet: "To determine the safety, tolerability, and recommended dose of MK-7075 in people with PS."
        explanation: The trial objective defines dose-finding and safety assessment in Proteus syndrome.
  - name: NCT03094832
    phase: PHASE_I
    status: TERMINATED
    description: Phase 1/2 open-label study of oral miransertib (MK-7075) in PROS and Proteus syndrome (MOSAIC).
    evidence:
      - reference: clinicaltrials:NCT03094832
        supports: SUPPORT
        snippet: "This is an open label, Phase 1/2 study of oral miransertib (MK-7075) administered to participants at least 2 years of age with phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA)-related Overgrowth Spectrum (PROS) and Proteus Syndrome (PS) (MOSAIC)."
        explanation: The trial summary describes the Phase 1/2 MOSAIC study including Proteus syndrome.
  - name: NCT04980872
    phase: PHASE_II
    status: ACTIVE_NOT_RECRUITING
    description: Extension study evaluating safety/tolerability of oral miransertib in PROS or Proteus syndrome.
    evidence:
      - reference: clinicaltrials:NCT04980872
        supports: SUPPORT
        snippet: "This is a study of the safety and tolerability of oral miransertib (MK-7075) administered to participants at least 2 years of age with phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)-related overgrowth spectrum (PROS) or Proteus Syndrome (PS)."
        explanation: The study summary states the safety/tolerability focus for PROS or Proteus syndrome participants.
  - name: NCT03317366
    phase: NOT_APPLICABLE
    status: UNKNOWN
    description: Expanded access for ARQ 092 (miransertib) in overgrowth diseases or vascular anomalies with PI3K/AKT alterations.
    evidence:
      - reference: clinicaltrials:NCT03317366
        supports: SUPPORT
        snippet: "ARQ 092 is being investigated for patients with overgrowth diseases and/or vascular anomalies with genetic alterations of the PI3K/AKT pathway and may be available for patients who are ineligible for an ongoing ARQ 092 clinical trial or have other considerations that prevent access to ARQ 092 through an existing clinical trial."
        explanation: The summary describes expanded access for PI3K/AKT-pathway overgrowth disorders including Proteus syndrome.
  - name: NCT00001403
    phase: NOT_APPLICABLE
    status: RECRUITING
    description: Natural history study of Proteus syndrome and related congenital overgrowth disorders.
    evidence:
      - reference: clinicaltrials:NCT00001403
        supports: SUPPORT
        snippet: "This study will examine rare congenital disorders that involve malformations and abnormal growth. It will focus on patients with Proteus syndrome, whose physical features are characterized by overgrowth, benign tumors of fatty tissue or blood vessels, asymmetric arms or legs, and large feet with very thick soles."
        explanation: The study description states a natural history focus on Proteus syndrome.
datasets: []
